IO Biotech, Inc. (IOBTQ)
↓ Download CSVKey ratios (FY2024)
-203.1%
Return on equity
| Metric (FY) | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Income | -$95.18M | -$91.44M | -$71.42M | -$41.23M | -$10.14M | — |
| Net Income | -$95.49M | -$86.08M | -$71.46M | -$67.88M | -$12.04M | — |
| EPS (Diluted) | $-1.45 | $-1.98 | $-2.48 | $-17.30 | — | — |
| Total Assets | $67.70M | $150.72M | $151.81M | $222.29M | $5.65M | — |
| Total Liabilities | $20.68M | $17.56M | $12.95M | $10.36M | $3.05M | — |
| Shareholders' Equity | $47.02M | $133.16M | $138.85M | $211.92M | -$35.30M | -$23.53M |
| Cash & Equivalents | $60.03M | $143.19M | $142.59M | $211.53M | $3.40M | — |
| Operating Cash Flow | -$82.35M | -$71.74M | -$59.73M | -$40.65M | -$9.96M | — |
| Capital Expenditures | $44.0K | $323.0K | $690.0K | $153.0K | — | — |
| Shares Outstanding | 65.88M | 65.88M | 28.82M | 28.82M | 0 | — |